![](/img/cover-not-exists.png)
Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
Zhao, Binghao, Zhang, Wenxiong, Yu, Dongliang, Xu, Jianjun, Wei, YipingVolume:
122
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2018.05.011
Date:
August, 2018
File:
PDF, 1.03 MB
english, 2018